Cargando…
Attenuation of p53 mutant as an approach for treatment Her2-positive cancer
Breast cancer is one of the world’s leading causes of oncological disease-related death. It is characterized by a high degree of heterogeneity on the clinical, morphological, and molecular levels. Based on molecular profiling breast carcinomas are divided into several subtypes depending on the expre...
Autores principales: | Fedorova, Olga, Daks, Alexandra, Shuvalov, Oleg, Kizenko, Alena, Petukhov, Alexey, Gnennaya, Yulia, Barlev, Nikolai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548004/ https://www.ncbi.nlm.nih.gov/pubmed/33083021 http://dx.doi.org/10.1038/s41420-020-00337-4 |
Ejemplares similares
-
Emerging roles of cancer-testis antigenes, semenogelin 1 and 2, in neoplastic cells
por: Shuvalov, Oleg, et al.
Publicado: (2021) -
Opposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition
por: Semenov, Oleg, et al.
Publicado: (2022) -
Cancer-testis antigens, semenogelins 1 and 2, exhibit different anti-proliferative effects on human lung adenocarcinoma cells
por: Shuvalov, Oleg, et al.
Publicado: (2020) -
The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase
por: Daks, Alexandra, et al.
Publicado: (2021) -
SEMG1/2 augment energy metabolism of tumor cells
por: Shuvalov, Oleg, et al.
Publicado: (2020)